ChrisM
2021-06-18

$Orphazyme A/S(ORPH)$Just a bit of warning as most traders here came from wsb or something:

 The FDA rejected their primary drug candidate. This is why the stock is down so much pre-market as it's a death sentence for small biotech firms in the short to medium term.

Company will only recover either with:

1. New data to reverse FDA decision

2. New drugs

3. Some weird retail push, but please know that everyone will sell this besides crazy wsb people I guess.


Point 1 and 2 can take a long time. So till then this can be close to dead.

Please do research, biotech companies live or die by trial results and FDA decisions, this is not just a dip.

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

精彩评论

  • boredpanda
    2021-06-18
    boredpanda
    prime time to short then
发表看法
5